Hypothesis--haptoglobin genotype and diabetic nephropathy (Q36831657)

16 August 2017

1 reference

title

Hypothesis--haptoglobin genotype and diabetic nephropathy (English)

1 reference

16 August 2017

Farid M Nakhoul

1

1 reference

16 August 2017

Rachel Miller-Lotan

2

1 reference

16 August 2017

Huda Awaad

3

1 reference

16 August 2017

Rabea Asleh

4

1 reference

16 August 2017

Andrew P Levy

5

1 reference

16 August 2017

1 June 2007

1 reference

Nature Clinical Practice Nephrology

16 August 2017

1 reference

16 August 2017

3

1 reference

16 August 2017

339-344

1 reference

16 August 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/ncpneph0467

16 August 2017

0 references

cites work

Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

Diabetes, hypertension, and cardiovascular disease: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

Global and societal implications of the diabetes epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

7 January 2021

End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

7 January 2021

Oxidative stress and diabetic vascular complications

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

7 January 2021

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

7 January 2021

Diabetic nephropathy: worldwide epidemic and effects of current treatment on natural history

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

7 January 2021

Recent developments in the understanding and management of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

7 January 2021

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

7 January 2021

Diabetes and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

7 January 2021

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

7 January 2021

Familial Clustering of Cardiovascular Disease in Patients with Insulin-Dependent Diabetes and Nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

7 January 2021

Genetics of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

7 January 2021

Genetic susceptibility contributes to renal and cardiovascular complications of type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

7 January 2021

Biological and clinical significance of haptoglobin polymorphism in humans

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

7 January 2021

Haptoglobin: the evolutionary product of duplication, unequal crossing over, and point mutation

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

7 January 2021

Structure-function analysis of the antioxidant properties of haptoglobin

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

7 January 2021

Identification of the haemoglobin scavenger receptor.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

7 January 2021

Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

7 January 2021

Haptoglobin phenotype and vascular complications in patients with diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

7 January 2021

Haptoglobin phenotype and diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

7 January 2021

Haptoglobin genotype as a risk factor for diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

7 January 2021

Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

7 January 2021

Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

7 January 2021

Haptoglobin genotype is predictive of major adverse cardiac events in the 1-year period after percutaneous transluminal coronary angioplasty in individuals with diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

7 January 2021

Association between haptoglobin gene variants and diabetic nephropathy: haptoglobin polymorphism in nephropathy susceptibility

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

7 January 2021

Haptoglobin genotype and diabetic microangiopathies in Japanese diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

7 January 2021

Role of haptoglobin phenotype in end-stage kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

7 January 2021

Haptoglobin phenotype as a predictive factor of mortality in diabetic haemodialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

7 January 2021

A study of haptoglobin phenotypes in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

7 January 2021

Haptoglobin phenotype and prevalent coronary heart disease in the Framingham offspring cohort.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

7 January 2021

Haptoglobin Genotype Is a Determinant of Iron, Lipid Peroxidation, and Macrophage Accumulation in the Atherosclerotic Plaque

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

7 January 2021

Increased renal hypertrophy in diabetic mice genetically modified at the haptoglobin locus

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

7 January 2021

Retinal capillary basement membrane thickness in diabetic mice genetically modified at the haptoglobin locus

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

7 January 2021

Haptoglobin genotype is a regulator of reverse cholesterol transport in diabetes in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

7 January 2021

Acidic and neutral sialidase in the erythrocyte membrane of type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

7 January 2021

Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

7 January 2021

Haptoglobin genotype- and diabetes-dependent differences in iron-mediated oxidative stress in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

7 January 2021

Application of pharmacogenomics in the prevention of diabetic cardiovascular disease: mechanistic basis and clinical evidence for utilization of the haptoglobin genotype in determining benefit from antioxidant therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0467

7 January 2021

Identifiers

DOI

10.1038/NCPNEPH0467

1 reference

Dimensions Publication ID

16 August 2017

0 references

1 reference